Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459292 Nucleotide sequence encoding polypeptide; ligand binding to neuromedin; central nervous system and psychological disorders
12/02/2008US7459287 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
12/02/2008US7459286 Comparing myeloperoxidase or troponin levels in blood, serum or leukocytes; flow cytometry; lipid peroxidation products; dityrosine, nitrotyrosine, chlorotyrosine, methionine sulfoxide
12/02/2008US7459285 Using lipid phosphates activity profile as diagnostic tool for detection and treatment of cancer; pregnancy determination; kits
12/02/2008US7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
12/02/2008US7459281 Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects
12/02/2008US7459280 Staining tissue with antibodies specific against domain or epitope of cadherin epidermal growth factor G-type receptor proteins; immunohistochemical assay to detect absence of binding and decreased levels of protein in cells
12/02/2008US7459279 Determining if substance is ligand by contacting with cell and measuring modulation of intracellular calcium level; treatment of central nervous system and psychiatric disorders
12/02/2008US7459278 System and method for large scale detection of hazardous materials in the mail or in other objects
12/02/2008US7459277 Mammalian T1R3 sweet taste receptors
12/02/2008US7459276 Methods and controls for monitoring assay quality and accuracy in parathyroid hormone measurement
12/02/2008US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection
12/02/2008US7459271 Identifying genetic rearrangements associated with restriction fragment length polymorphisms using reverse or forward primers; genotyping vision, metabolic, cardiovascular, obese, nervous system disorders and muscular disorders
12/02/2008US7459269 Detection of viral infection in animals; obtain hair sample, incubate with antibody bound to solid support, detect signal, compare to control, evaluate for viral infection
12/02/2008US7459268 Identifying cell wall modulating agents using golgi associated proteins; fungicides
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection
12/02/2008US7459157 Contacting human fluids with antibody directed against Minichromosome Maintenance protein 7 (MCM7 protein) and determining amount of binding; cytology
12/02/2008US7459156 Antibodies that mimic actions of neurotrophins
12/02/2008US7459129 Retaining microfluidic microcavity and other microfluidic structures
12/02/2008US7459127 Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
12/02/2008US7459125 Device for determining an analyte in a liquid sample
12/02/2008US7459124 Detecting interactions at biomimetic interfaces with liquid crystals
12/02/2008US7458248 Method and apparatus to detect genuine or hoax contaminants
12/02/2008CA2475116C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
12/02/2008CA2370154C Method of determining the salt content of liquids and device for practicing the method
12/02/2008CA2359657C Microsensor housing
12/02/2008CA2348377C Human orphan g protein-coupled receptors
12/02/2008CA2300355C Detection of genetic alterations of chromosome 20q that are associated with breast cancer
12/02/2008CA2284170C Identification of agents for use in the treatment of alzheimer's disease
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2263439C Improved western blot test for the identification of antibodies specific against the hcmv virus
12/02/2008CA2236554C Immunoassay for determining the avidity of immunoglobulins
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2215397C Inhibition of tau-tau-association
12/02/2008CA2205085C An in vitro system for determining formation of a.beta. amyloid
12/02/2008CA2172663C Improved reagents for a cannabinoid immunoassay
12/01/2008CA2632829A1 Evaluating the probability that ms/ms spectral data matches candidate sequence data
12/01/2008CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof
11/2008
11/29/2008CA2590347A1 Internal and external wood rot indentification, for optimum trimming, using soft x-rays
11/27/2008WO2008144736A1 Parkin substrate and assay
11/27/2008WO2008144700A2 Simian t-cell lymphotropic virus type 3 west african subtype d
11/27/2008WO2008144646A1 Novel primate chitinases and uses therefor
11/27/2008WO2008144613A1 Biomarkers for the diagnosis and assessment of bipolar disorder
11/27/2008WO2008144610A1 Il-33 in inflammatory disease
11/27/2008WO2008144588A2 Rapid protein labeling and analysis
11/27/2008WO2008144560A1 Algorithms to predict clinical response, adherence, and shunting with thiopurines
11/27/2008WO2008144509A1 Method for diagnosis and treatment of pancreatic cancer
11/27/2008WO2008144481A1 Measurement and uses of oxidative status
11/27/2008WO2008144474A1 System and method for monitoring performance of a spraying device
11/27/2008WO2008144426A1 Gas sample collection and analysis
11/27/2008WO2008144371A1 Methods and compositions for diagnosing suicidal tendencies
11/27/2008WO2008144301A1 Apparatus and methods for the detection of plasma metanephrines
11/27/2008WO2008144242A1 Real-time individualized therapy evaluation
11/27/2008WO2008144142A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/27/2008WO2008144085A1 Compositions and methods for combining report antibodies
11/27/2008WO2008144041A1 Hepcidins as biomarkers for impending lupus nephritis flare
11/27/2008WO2008144034A1 Serum biomarkers for the early detection of lung cancer
11/27/2008WO2008144032A1 Phosphoproteomic evaluation of diabetes and obesity
11/27/2008WO2008144021A2 Ex vivo methods for validating substance testing with human organs and/or tissues
11/27/2008WO2008144020A1 Ex vivo methods for testing organ system disruption
11/27/2008WO2008143919A1 Biomarkers for psychosis
11/27/2008WO2008143908A2 Computational user-health testing
11/27/2008WO2008143890A2 Biomarkers for septic shock patients
11/27/2008WO2008143888A1 Multiwell plate device
11/27/2008WO2008143883A1 Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (rct)
11/27/2008WO2008143879A2 Vitamin e supplementation for reducing cardiovascular events in individuals with dm and the hp 2-2 genotype
11/27/2008WO2008143873A1 Identification of oxidatively modified peptide sequences in the proteome
11/27/2008WO2008143795A1 Human mesenchymal chrondrosarcoma xenograft model and its use in chemosensitivity testing
11/27/2008WO2008143731A2 Surface grafted conjugated polymers
11/27/2008WO2008143684A1 Methods of generation use of in vivo biotinylated recombinant antibodies
11/27/2008WO2008143669A1 Assessing outcomes for breast cancer patients
11/27/2008WO2008143578A1 Separation method and device
11/27/2008WO2008143570A1 Separation device
11/27/2008WO2008143519A1 Mr methods of grading a tumor using an imaging medium that comprises hyperpolarised 13c-pyruvate
11/27/2008WO2008143494A1 Assay for detection of prostate cancer by means of proteolytic hsa markers
11/27/2008WO2008143406A1 Trichomonas vaginalis diagnostic kit
11/27/2008WO2008143351A1 Chemical surface nanopatterns to increase activity of surface-immobilized biomolecules
11/27/2008WO2008143192A1 Identification of transporter in charge of chemical transmission of aspartic acid and application thereof
11/27/2008WO2008143171A1 Method for evaluating gastric mucosal state by quantifying helicobacter pylori antigen in feces
11/27/2008WO2008143170A1 Method for quantitative analysis of tin or tin alloy plating layer
11/27/2008WO2008143159A1 Method and kit for measurement of cholesterol in low-density lipoprotein
11/27/2008WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
11/27/2008WO2008143145A1 Skin-moisturizing effect evaluation method, and screening method for moisturizing substance by using the evaluation method
11/27/2008WO2008143127A1 Method of measuring the activity of lipid-modified enzyme
11/27/2008WO2008143110A1 Sensor chip for detection of antigen, method for production of the sensor chip, and sensor for detection of antigen
11/27/2008WO2008143109A1 Sensor chip for detection of antigen, method for production of the sensor chip, and sensor for detection of antigen
11/27/2008WO2008142888A1 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indications
11/27/2008WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules
11/27/2008WO2008142492A1 Method for detecting label particles
11/27/2008WO2008142405A1 Method for predicting the response of a patient to treatment with an anti-tnf alpha antibody
11/27/2008WO2008142396A1 Methods of assessing male fertility using a uridine marker
11/27/2008WO2008142194A1 Method for the in vitro diagnosis/prognosis of huntington's chorea
11/27/2008WO2008142165A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008WO2008142157A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008WO2008142110A1 Means and methods for assessing heart failure in patients with atrial fibrillation using gdf-15 and natriuretic peptides
11/27/2008WO2008142057A1 Turbidimetric immunoassay for assessing human cystatin c
11/27/2008WO2008141659A1 Test chip with plug for measuring the concentration of an analyte in a liquid, housing for test chip and socket for plug
1 ... 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 ... 3937